Atlas Trials

Benralizumab for Eosinophilic Gastritis (BEGS)

Clinical trial NCT03473977 · COMPLETED

Trial details

NCT number
NCT03473977
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Eosinophilic Gastritis or Gastroenteritis
Start date
2018-04-23
Primary completion
2020-06-22
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.